Maravai Lifesciences Price To Earning vs. Gross Profit

MRVI Stock  USD 5.67  0.01  0.18%   
Based on Maravai Lifesciences' profitability indicators, Maravai Lifesciences' profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Maravai Lifesciences' ability to earn profits and add value for shareholders. The current Price To Sales Ratio is estimated to decrease to 2.84. The current Days Sales Outstanding is estimated to decrease to 45.78. As of now, Maravai Lifesciences' Interest Income is increasing as compared to previous years. The Maravai Lifesciences' current Change To Netincome is estimated to increase to about 386.4 M, while Net Interest Income is projected to decrease to (19 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.520.4852
Notably Up
Slightly volatile
For Maravai Lifesciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Maravai Lifesciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Maravai Lifesciences Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Maravai Lifesciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Maravai Lifesciences Holdings over time as well as its relative position and ranking within its peers.
  

Maravai Lifesciences' Revenue Breakdown by Earning Segment

Check out Correlation Analysis.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.33)
Earnings Share
(1.67)
Revenue Per Share
2.044
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.02)
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Maravai Lifesciences Gross Profit vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Maravai Lifesciences's current stock value. Our valuation model uses many indicators to compare Maravai Lifesciences value to that of its competitors to determine the firm's financial worth.
Maravai Lifesciences Holdings is regarded second in price to earning category among its peers. It is considered to be number one stock in gross profit category among its peers fabricating about  91,661,617  of Gross Profit per Price To Earning. As of now, Maravai Lifesciences' Gross Profit is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Maravai Lifesciences' earnings, one of the primary drivers of an investment's value.

Maravai Lifesciences' Earnings Breakdown by Geography

Maravai Gross Profit vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Maravai Lifesciences

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
7.79 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Maravai Lifesciences

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
714.04 M
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Maravai Gross Profit Comparison

Maravai Lifesciences is currently under evaluation in gross profit category among its peers.

Maravai Lifesciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Maravai Lifesciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Maravai Lifesciences will eventually generate negative long term returns. The profitability progress is the general direction of Maravai Lifesciences' change in net profit over the period of time. It can combine multiple indicators of Maravai Lifesciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Interest Income-18.1 M-19 M
Operating Income-31.6 M-30.1 M
Net Income From Continuing Ops59 M56.1 M
Income Before Tax617.7 M322.5 M
Total Other Income Expense Net649.4 M681.9 M
Net Income Applicable To Common Shares253.2 M265.9 M
Net Loss-119 M-113.1 M
Income Tax Expense756.1 M793.9 M
Interest Income22.6 M23.7 M
Non Operating Income Net Other251.1 K223.2 K
Change To Netincome368 M386.4 M
Net Loss(0.90)(0.86)
Income Quality(1.06)(1.01)
Net Loss(0.19)(0.18)

Maravai Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Maravai Lifesciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Maravai Lifesciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Maravai Lifesciences' important profitability drivers and their relationship over time.

Use Maravai Lifesciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Maravai Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maravai Lifesciences will appreciate offsetting losses from the drop in the long position's value.

Maravai Lifesciences Pair Trading

Maravai Lifesciences Holdings Pair Trading Analysis

The ability to find closely correlated positions to Maravai Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Maravai Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Maravai Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Maravai Lifesciences Holdings to buy it.
The correlation of Maravai Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Maravai Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Maravai Lifesciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Maravai Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Maravai Lifesciences position

In addition to having Maravai Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Funds Thematic Idea Now

Small Growth Funds
Small Growth Funds Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Maravai Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Maravai Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maravai Lifesciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maravai Lifesciences Holdings Stock:
To fully project Maravai Lifesciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Maravai Lifesciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Maravai Lifesciences' income statement, its balance sheet, and the statement of cash flows.
Potential Maravai Lifesciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Maravai Lifesciences investors may work on each financial statement separately, they are all related. The changes in Maravai Lifesciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Maravai Lifesciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.